
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (China), China, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
50%
Total
Publications
264
Total Open
Publications
131
Total
Citations
12K
Open Access
Percentage
50%
Total
Publications
264
Total Open
Publications
131
Total
Citations
12K
Breakdown
Publisher Open
23%
Both
17%
Other Platform Open
9%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
39
Hybrid 22%
23
No Guarantees 41%
43
Other Platform Open
Domain 75%
51
Institution 16%
11
Other Internet 16%
11
Preprint 6%
4
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 51 |
DOI | Other Internet | 10 |
Research Square | Preprint | 2 |
Europe PMC | Domain | 2 |
Yonsei University | Institution | 1 |
Unknown Repository | Other Internet | 1 |
University of Milan | Institution | 1 |
University of Michigan–Ann Arbor | Institution | 1 |
University of Melbourne | Institution | 1 |
University of Adelaide | Institution | 1 |